Bidirectional transfer of methadone across human placenta

Ilona A. Nekhayeva, Tatiana Nanovskaya, Sujal V. Deshmukh, Olga L. Zharikova, Gary Hankins, Mahmoud Ahmed

Research output: Contribution to journalArticle

58 Citations (Scopus)

Abstract

Methadone maintenance programs are considered the standard of care for the pregnant opiate addict. However, data on changes in methadone pharmacokinetics (PK) during pregnancy are limited and do not include its disposition by the placenta due to obvious ethical and safety considerations. Accordingly, investigations in our laboratory are focusing on human placental disposition of opiates including methadone. Recently, we reported on methadone metabolism by placental aromatase and provide here data on its bidirectional transfer across the tissue utilizing the technique of dual perfusion of placental lobule. The concentrations of the opiate transfused into the term placental tissue were those reported for its in vivo levels in the maternal serum of women under treatment with the drug. Data obtained indicated that the opiate has no adverse effects on placental viability and functional parameters and that it is retained by the tissue. Also, methadone transfer and its clearance index in the fetal to maternal direction (0.97 ± 0.05) was significantly higher (P < 0.05) than in the maternal to fetal (0.83 ± 0.09). The observed asymmetry in methadone transfer could be explained by the unidirectional activity of the efflux transporter P glycoprotein (P-gp) that is highly expressed in variable amounts in trophoblast tissue. Therefore, placental disposition of methadone might be an important contributor to the regulation of its concentration in the fetal circulation and consequently may affect the incidence and intensity of neonatal abstinence syndrome for women treated with the drug during pregnancy.

Original languageEnglish (US)
Pages (from-to)187-197
Number of pages11
JournalBiochemical Pharmacology
Volume69
Issue number1
DOIs
StatePublished - Jan 1 2005

Fingerprint

Methadone
Opiate Alkaloids
Placenta
Tissue
Mothers
Neonatal Abstinence Syndrome
Pregnancy
Pharmacokinetics
Aromatase
Trophoblasts
P-Glycoprotein
Standard of Care
Metabolism
Pharmaceutical Preparations
Perfusion
Safety
Incidence
Serum

Keywords

  • Human placenta
  • Methadone
  • Pregnancy
  • Transplacental transfer

ASJC Scopus subject areas

  • Pharmacology

Cite this

Bidirectional transfer of methadone across human placenta. / Nekhayeva, Ilona A.; Nanovskaya, Tatiana; Deshmukh, Sujal V.; Zharikova, Olga L.; Hankins, Gary; Ahmed, Mahmoud.

In: Biochemical Pharmacology, Vol. 69, No. 1, 01.01.2005, p. 187-197.

Research output: Contribution to journalArticle

Nekhayeva, Ilona A. ; Nanovskaya, Tatiana ; Deshmukh, Sujal V. ; Zharikova, Olga L. ; Hankins, Gary ; Ahmed, Mahmoud. / Bidirectional transfer of methadone across human placenta. In: Biochemical Pharmacology. 2005 ; Vol. 69, No. 1. pp. 187-197.
@article{467841fbcee7477dab92bf5f286f5b2c,
title = "Bidirectional transfer of methadone across human placenta",
abstract = "Methadone maintenance programs are considered the standard of care for the pregnant opiate addict. However, data on changes in methadone pharmacokinetics (PK) during pregnancy are limited and do not include its disposition by the placenta due to obvious ethical and safety considerations. Accordingly, investigations in our laboratory are focusing on human placental disposition of opiates including methadone. Recently, we reported on methadone metabolism by placental aromatase and provide here data on its bidirectional transfer across the tissue utilizing the technique of dual perfusion of placental lobule. The concentrations of the opiate transfused into the term placental tissue were those reported for its in vivo levels in the maternal serum of women under treatment with the drug. Data obtained indicated that the opiate has no adverse effects on placental viability and functional parameters and that it is retained by the tissue. Also, methadone transfer and its clearance index in the fetal to maternal direction (0.97 ± 0.05) was significantly higher (P < 0.05) than in the maternal to fetal (0.83 ± 0.09). The observed asymmetry in methadone transfer could be explained by the unidirectional activity of the efflux transporter P glycoprotein (P-gp) that is highly expressed in variable amounts in trophoblast tissue. Therefore, placental disposition of methadone might be an important contributor to the regulation of its concentration in the fetal circulation and consequently may affect the incidence and intensity of neonatal abstinence syndrome for women treated with the drug during pregnancy.",
keywords = "Human placenta, Methadone, Pregnancy, Transplacental transfer",
author = "Nekhayeva, {Ilona A.} and Tatiana Nanovskaya and Deshmukh, {Sujal V.} and Zharikova, {Olga L.} and Gary Hankins and Mahmoud Ahmed",
year = "2005",
month = "1",
day = "1",
doi = "10.1016/j.bcp.2004.09.008",
language = "English (US)",
volume = "69",
pages = "187--197",
journal = "Biochemical Pharmacology",
issn = "0006-2952",
publisher = "Elsevier Inc.",
number = "1",

}

TY - JOUR

T1 - Bidirectional transfer of methadone across human placenta

AU - Nekhayeva, Ilona A.

AU - Nanovskaya, Tatiana

AU - Deshmukh, Sujal V.

AU - Zharikova, Olga L.

AU - Hankins, Gary

AU - Ahmed, Mahmoud

PY - 2005/1/1

Y1 - 2005/1/1

N2 - Methadone maintenance programs are considered the standard of care for the pregnant opiate addict. However, data on changes in methadone pharmacokinetics (PK) during pregnancy are limited and do not include its disposition by the placenta due to obvious ethical and safety considerations. Accordingly, investigations in our laboratory are focusing on human placental disposition of opiates including methadone. Recently, we reported on methadone metabolism by placental aromatase and provide here data on its bidirectional transfer across the tissue utilizing the technique of dual perfusion of placental lobule. The concentrations of the opiate transfused into the term placental tissue were those reported for its in vivo levels in the maternal serum of women under treatment with the drug. Data obtained indicated that the opiate has no adverse effects on placental viability and functional parameters and that it is retained by the tissue. Also, methadone transfer and its clearance index in the fetal to maternal direction (0.97 ± 0.05) was significantly higher (P < 0.05) than in the maternal to fetal (0.83 ± 0.09). The observed asymmetry in methadone transfer could be explained by the unidirectional activity of the efflux transporter P glycoprotein (P-gp) that is highly expressed in variable amounts in trophoblast tissue. Therefore, placental disposition of methadone might be an important contributor to the regulation of its concentration in the fetal circulation and consequently may affect the incidence and intensity of neonatal abstinence syndrome for women treated with the drug during pregnancy.

AB - Methadone maintenance programs are considered the standard of care for the pregnant opiate addict. However, data on changes in methadone pharmacokinetics (PK) during pregnancy are limited and do not include its disposition by the placenta due to obvious ethical and safety considerations. Accordingly, investigations in our laboratory are focusing on human placental disposition of opiates including methadone. Recently, we reported on methadone metabolism by placental aromatase and provide here data on its bidirectional transfer across the tissue utilizing the technique of dual perfusion of placental lobule. The concentrations of the opiate transfused into the term placental tissue were those reported for its in vivo levels in the maternal serum of women under treatment with the drug. Data obtained indicated that the opiate has no adverse effects on placental viability and functional parameters and that it is retained by the tissue. Also, methadone transfer and its clearance index in the fetal to maternal direction (0.97 ± 0.05) was significantly higher (P < 0.05) than in the maternal to fetal (0.83 ± 0.09). The observed asymmetry in methadone transfer could be explained by the unidirectional activity of the efflux transporter P glycoprotein (P-gp) that is highly expressed in variable amounts in trophoblast tissue. Therefore, placental disposition of methadone might be an important contributor to the regulation of its concentration in the fetal circulation and consequently may affect the incidence and intensity of neonatal abstinence syndrome for women treated with the drug during pregnancy.

KW - Human placenta

KW - Methadone

KW - Pregnancy

KW - Transplacental transfer

UR - http://www.scopus.com/inward/record.url?scp=9944263496&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=9944263496&partnerID=8YFLogxK

U2 - 10.1016/j.bcp.2004.09.008

DO - 10.1016/j.bcp.2004.09.008

M3 - Article

VL - 69

SP - 187

EP - 197

JO - Biochemical Pharmacology

JF - Biochemical Pharmacology

SN - 0006-2952

IS - 1

ER -